BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35414437)

  • 1. Prospective multicenter survey for Nursing and Healthcare-associated Pneumonia in Japan.
    Imamura Y; Miyazaki T; Watanabe A; Tsukada H; Nagai H; Hasegawa Y; Tomono K; Ito I; Teramoto S; Ishida T; Kadota JI; Kohno S; Mukae H
    J Infect Chemother; 2022 Aug; 28(8):1125-1130. PubMed ID: 35414437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP).
    Fukuyama H; Yamashiro S; Tamaki H; Kishaba T
    J Infect Chemother; 2013 Aug; 19(4):719-26. PubMed ID: 23354936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of nursing and healthcare-associated pneumonia: a Japanese variant of healthcare-associated pneumonia.
    Ishida T; Tachibana H; Ito A; Yoshioka H; Arita M; Hashimoto T
    Intern Med; 2012; 51(18):2537-44. PubMed ID: 22989823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP).
    Kaku N; Yanagihara K; Morinaga Y; Izumikawa K; Nagashima S; Kakeya H; Yamamoto Y; Fukuda M; Takatani H; Fukuda M; Hashiguchi K; Kohno S
    J Infect Chemother; 2013 Feb; 19(1):70-6. PubMed ID: 22850821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of urinary tract infection on nursing and healthcare-associated pneumonia.
    Yamazoe M; Tomioka H; Wada T
    J Infect Chemother; 2019 Dec; 25(12):950-954. PubMed ID: 31196770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital.
    Miyashita N; Kawai Y; Akaike H; Ouchi K; Hayashi T; Kurihara T; Okimoto N
    Intern Med; 2012; 51(6):585-94. PubMed ID: 22449666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical profile in elderly patients with nursing and healthcare-associated pneumonia, and those with community-acquired pneumonia.
    Nakagawa N; Saito Y; Sasaki M; Tsuda Y; Mochizuki H; Takahashi H
    Geriatr Gerontol Int; 2014 Apr; 14(2):362-71. PubMed ID: 23829585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluation of the Japanese guideline for healthcare-associated pneumonia in a medium-sized community hospital in Japan.
    Oshitani Y; Nagai H; Matsui H; Aoshima M
    J Infect Chemother; 2013 Aug; 19(4):579-87. PubMed ID: 23179959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pneumonia severity scoring systems in nursing and healthcare-associated pneumonia for predicting prognosis: A prospective, cohort study.
    Ito A; Ishida T; Tokumasu H; Yamazaki A; Washio Y
    J Infect Chemother; 2020 Apr; 26(4):372-378. PubMed ID: 31787528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is antipseudomonal antibiotic treatment needed for all nursing and healthcare-associated pneumonia patients at risk for antimicrobial resistance?
    Ito A; Ishida T; Tachibana H; Nakanishi Y; Yamazaki A; Washio Y
    J Glob Antimicrob Resist; 2020 Sep; 22():441-447. PubMed ID: 32339851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiological analysis and epidemiological comparison among adult CAP and NHCAP patients in Okinawa, Japan.
    Parrott G; Nebeya D; Kinjo T; Miyagi K; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2017 Jul; 23(7):452-458. PubMed ID: 28431934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A-DROP system for prognostication of NHCAP inpatients.
    Koizumi T; Tsukada H; Ito K; Shibata S; Hokari S; Tetsuka T; Aoki N; Moro H; Tanabe Y; Kikuchi T
    J Infect Chemother; 2017 Aug; 23(8):523-530. PubMed ID: 28549532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of nursing and healthcare-associated pneumonia due to COVID-19.
    Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y; Nomura S
    J Infect Chemother; 2022 Jul; 28(7):902-906. PubMed ID: 35317976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in nursing and healthcare-associated pneumonia.
    Yamagata A; Ito A; Nakanishi Y; Ishida T
    J Infect Chemother; 2020 Jun; 26(6):563-569. PubMed ID: 32067902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of nursing and healthcare-associated pneumonia: analysis of adverse prognostic factors and validity of the selection criteria.
    Sakoda Y; Ikegame S; Ikeda-Harada C; Takakura K; Kumazoe H; Wakamatsu K; Nakanishi Y; Kawasaki M
    Respir Investig; 2014 Mar; 52(2):114-20. PubMed ID: 24636267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nursing and healthcare-associated pneumonia due to SARS-CoV-2 Omicron variant.
    Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y; Ito T
    Respir Investig; 2024 Mar; 62(2):252-257. PubMed ID: 38241958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of lascufloxacin for nursing- and healthcare-associated pneumonia: A single-arm, open-label clinical trial.
    Takazono T; Hosogaya N; Fukushima K; Morio R; Irifune S; Miyamura T; Harada Y; Nagayoshi Y; Kondo A; Mihara T; Fukuda Y; Sasaki E; Sawai T; Imamura Y; Morikawa T; Futsuki Y; Inoue Y; Fukushima K; Suyama N; Tanaka H; Hanaka T; Shimabukuro I; Hata R; Ota K; Morimoto S; Nakada N; Ito Y; Yoshida M; Takeda K; Ide S; Iwanaga N; Nemoto K; Funada M; Izumikawa K; Yatera K; Yanagihara K; Mukae H
    J Infect Chemother; 2024 Jul; 30(7):597-602. PubMed ID: 38190963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19.
    Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y
    J Infect Chemother; 2023 May; 29(5):437-442. PubMed ID: 36567049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of efficacy and safety of lascufloxacin for nursing and healthcare associated pneumonia: single-arm, open-label clinical trial: A study protocol.
    Hosogaya N; Takazono T; Ota K; Kiya R; Shirai Y; Kawasaki R; Yano H; Morimoto S; Nakao R; Kanamaru Y; Yoshino Y; Ishikawa Y; Fukushima C; Yamamoto H; Izumikawa K; Yanagihara K; Mukae H
    Medicine (Baltimore); 2023 Feb; 102(8):e33092. PubMed ID: 36827005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.